SAVE MONEY ON TRAVEL DEALS

"In our study, multitarget therapy is shown to be superior to traditional therapy for inducing complete remission of class V+IV lupus nephritis, with few side effects", said Dr. Lei-Shi Li of the University School of Medicine in Nanjing, China.

Lupus nephritis is inflammation of the kidneys occurring in patients with systemic lupus erythematosus, or SLE. All patients had "class V+IV" disease, meaning widespread inflammation and decreasing kidney function.

The disease is traditionally treated with a single immunosuppressant drug, said Li, adding: "We considered that, since the impact of severe SLE on the kidney involves various parts of the immune system, it is necessary to treat the different immune targets with a combination of immunosuppressant drugs."

Patients receiving the immunosuppressant drugs tacrolimus and mycophenolate mofetil, plus a steroid, showed complete remission, with recovery of normal kidney function about four times higher than conventionally treated patients. "The complete remission rate reached 65 percent at nine months versus only 15 percent under traditional therapy", Li said.

The study appears in the Journal of the American Society of Nephrology.

 BREAKING STORIES

U.N. moves to help India, Nepal flooding

Fast thinking saves flies' lives

Increase in bone fractures linked to HIV

CSPI wants more tests for rebiana

Tire companies to lose tire weights

Pythons may help heal hearts

Chewing gum may reduce stress

N.J. lifts ban on Delaware shellfishing

EPA completes river cleanup

Obesity inflammation not linked to asthma

Fla. wildlife seeks high ground after Fay

Study: Happiness linked to better health

Court backs mad cow testing limits

Report: Flu shot benefits exaggerated

Expert: How to curb hurricane anxiety

Class of diabetes drugs may up heart risk

Last Mount Olympus bear killed

Workers in high-quality jobs thriving

Blogger Could Get Jail Time for GNR Leak

Russia launches five satellites into orbit